Associations of insulin resistance with cardiovascular risk factors and inflammatory cytokines in normal- Weight hispanic women

Diabetes Care

Volumn 36, Issue 5, 2013, Pages 1377-1383

  Vella, Chantal A ^a   Burgos, Ximena ^b   Ellis, Carla J ^b   Zubia, Raul Y ^b   Ontiveros, Diana ^b   Reyes, Hector ^b   Lozano, Claudia ^b  

^a UNIVERSITY OF IDAHO   (United States)

^b UNIVERSITY OF TEXAS AT EL PASO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT FREE MASS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HIGH RISK POPULATION; HISPANIC; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; PHYSICAL ACTIVITY; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ABSORPTIOMETRY, PHOTON; ADULT; BODY COMPOSITION; BODY WEIGHT; CARDIOVASCULAR DISEASES; CYTOKINES; FEMALE; HISPANIC AMERICANS; HUMANS; INSULIN RESISTANCE; RISK FACTORS; YOUNG ADULT;

EID: 84876796012     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1550     Document Type: Article

References (38)

1. Ruige JB, Assendelft WJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM. Insulin and risk of cardiovascular disease: A meta-analysis. Circulation 1998;97:996-1001 (Pubitemid 28125472)
2. Wingard DL, Barrett-Connor EL, Ferrara A. Is insulin really a heart disease risk factor. Diabetes Care 1995;18:1299-1304
3. Hanley AJ, Williams K, Stern MP, Haffner SM. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 2002; 25:1177-1184 (Pubitemid 41071169)
4. Xun P, Liu K, Cao W, Sidney S, Williams OD, He K. Fasting insulin level is positively associated with incidence of hypertension among American young adults: A 20-year follow-up study. Diabetes Care 2012;35: 1532-1537
5. Sandeep S, Gokulakrishnan K, Deepa M, Mohan V. Insulin resistance is associated with increased cardiovascular risk in Asian Indians with normal glucose tolerancedthe Chennai Urban Rural Epidemiology Study (CURES-66). J Assoc Physicians India 2011;59:480-484
6. Katsuki A, Sumida Y, Urakawa H, et al. Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care 2003;26:2341-2344 (Pubitemid 36993323)
7. Lin KC, Tsai ST, Kuo SC, Tsay SL, Chou P. Interrelationship between insulin resistance and menopause on the metabolic syndrome and its individual component among nondiabetic women in the kinmen study. Am J Med Sci 2007;333:208-214 (Pubitemid 46624809)
8. Marques-Vidal P, Bastardot F, von Känel R, et al. Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study). Clin Endocrinol (Oxf) 12 March 2012 [Epub ahead of print]
9. Olson NC, Callas PW, Hanley AJ, et al. Circulating levels of TNF-a are associated with impaired glucose tolerance, increased insulin resistance, and ethnicity: the Insulin Resistance Atherosclerosis Study. J Clin Endocrinol Metab 2012;97: 1032-1040
10. Dvorak RV, DeNino WF, Ades PA, Poehlman ET. Phenotypic characteristics associated with insulin resistance in met-abolically obese but normal-weight young women. Diabetes 1999;48:2210-2214 (Pubitemid 29521852)
11. Ho RC, Davy KP, Hickey MS, Summers SA, Melby CL. Behavioral, metabolic, and molecular correlates of lower insulin sensitivity in Mexican-Americans. Am J Physiol Endocrinol Metab 2002;283: E799-E808
12. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359 (Pubitemid 34251969)
13. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 2006;29:1263-1268 (Pubitemid 44125920)
14. St-Onge MP, Janssen I, Heymsfield SB. Metabolic syndrome in normal-weight Americans: new definition of the metabol-ically obese, normal-weight individual. Diabetes Care 2004;27:2222-2228 (Pubitemid 39167189)
15. Winkleby MA, Kraemer HC, Ahn DK, Varady AN. Ethnic and socioeconomic differences in cardiovascular disease risk factors: findings for women from the Third National Health and Nutrition Examination Survey, 1988-1994. JAMA 1998;280:356-362 (Pubitemid 28503220)
16. Lloyd-Jones DM, Leip EP, Larson MG, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006;113: 791-798
17. Stamler J, Stamler R, Neaton JD, et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999;282:2012-2018
18. National Heart Lung Blood Institute, Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Bethesda, MD, National Heart Lung and Blood Institute, 1998, Report 98-4083.
19. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
20. American College of Sports Medicine. ACSM's guidelines for exercise testing and prescription. 8th ed. Baltimore, MD, Lip-pincott Williams & Wilkins, 2009
21. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860-867 (Pubitemid 46024993)
22. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010;316:129-139
23. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843 (Pubitemid 30165206)
24. Malita FM, Karelis AD, St-Pierre DH, et al. Surrogate indexes vs. euglycaemic-hyperinsulinemic clamp as an indicator of insulin resistance and cardiovascular risk factors in overweight and obese post-menopausal women. Diabetes Metab 2006; 32:251-255 (Pubitemid 43966749)
25. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements inmedical research.BMJ 1990;300: 230-235 (Pubitemid 20045528)
26. Matthews CE, Ainsworth BE, Thompson RW, Bassett DR Jr. Sources of variance in daily physical activity levels as measured by an accelerometer. Med Sci Sports Exerc 2002;34:1376-1381 (Pubitemid 34840039)
27. Robergs RA, Dwyer D, Astorino T. Recommendations for improved data processing from expired gas analysis indirect calorimetry. Sports Med 2010;40:95-111
28. Vella CA, Zubia RY, Ontiveros D, Cruz ML. Physical activity, cardiorespiratory fitness, and metabolic syndrome in young Mexican and Mexican-American women. Appl Physiol Nutr Metab 2009;34:10-17
29. Centers for Disease Control and Prevention. National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA, Department of Health and Human Services, 2011
30. Gustafson B. Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb 2010;17:332-341
31. Harwood HJ Jr. The adipocyte as an endocrine organ in the regulation of metabolic homeostasis. Neuropharmacology 2012;63:57-75
32. Hanley AJ, Bowden D, Wagenknecht LE, et al. Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans. J Clin Endocrinol Metab 2007; 92:2665-2671 (Pubitemid 47037374)
33. Mohan V, Deepa R, Pradeepa R, et al. Association of low adiponectin levels with the metabolic syndrome-the Chennai Urban Rural Epidemiology Study (CURES-4). Metabolism 2005;54:476-481 (Pubitemid 40410448)
34. Festa A, D'Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-47 (Pubitemid 30430551)
35. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women. Circulation 2003;107:391-397
36. Pittas AG, Joseph NA, Greenberg AS. Adipocytokines and insulin resistance. J Clin Endocrinol Metab 2004;89:447-452 (Pubitemid 38269842)
37. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444:840-846 (Pubitemid 46024990)
38. Ruderman NB, Schneider SH, Berchtold P. The "metabolically-obese, " normal-weight individual. Am J Clin Nutr 1981; 34:1617-1621